Medicine Today, Money Tomorrow

How today’s Big Pharma will merge with tomorrow’s Big Finance

“Labelled glass bottles with various powders and liquids” by Matt Briney on Unsplash

Gilead, a major Big Pharma company, is in a bit of a bind. Their problem? Sales of some of their key drugs are tanking. Why’s that? Because they work too well.

In 2013, the United States FDA approved Gilead’s new hepatitis C drug, Sovaldi. Immediately, patients who might otherwise…